Log In
BCIQ
Print this Print this
 

RhoGAM

  Manage Alerts
Collapse Summary General Information
Company Kedrion Group S.p.A.
DescriptionRho(D) immune globulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard Indication Hematology (unspecified)
Indication DetailsPrevention of Rh immunization in any Rh-negative person after incompatible transfusion of Rh-positive blood or blood products
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/06/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today